eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

International Medication Systems (UK) Ltd

208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: medicalinformationuk@ucb.com
Customer Care direct line: +44 (0)800 953 0183
Medical Information Fax: +44 (0)1753 447 647

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 07/04/2010
SPC Naloxone Hydrochloride Injection, Minijet.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/04/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Feb-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Please note that we need to make a minor change to the EMC SPC.

The approval date should be February 2010.

Updated on 03/12/2009 and displayed until 07/04/2010
Reasons for adding or updating:
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01-Nov-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


In section  4.6 – Use during pregnancy and lactation  to add “Naloxone rapidly crosses the placental barrier so that some therapeutic effect may be anticipated in the neonate”


In section 4.8 – Undesirable Effects to add "violent behaviour as a symptom of abrupt reversal of narcotic depression and the rare occurrence of seizure from the administration of Naloxone"
Updated on 04/09/2007 and displayed until 03/12/2009
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
Date of revision of text on the SPC:   07/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Shelf-life increased from 2-3 years.
Updated on 24/11/2005 and displayed until 04/09/2007
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 3 - pharmaceutical form
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 4 - Special Precautions for Storage
Updated on 03/10/2003 and displayed until 24/11/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/06/2001 and displayed until 03/10/2003
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   naloxone hydrochloride dihydrate